Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

The Role of Practice Based Research Networks (PBRN) in the Spectrum of Clinical Trials

Go back to Resources

The Role of Practice Based Research Networks (PBRN) in the Spectrum of Clinical Trials

Authors:

Go back to Resources

The Relationship of Dietary Lipid Intake and Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 20

Go back to Resources

The Relationship of Dietary Lipid Intake and Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 20

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake with Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22

Go back to Resources

The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake with Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The NCI Pediatric Central Institutional Review Board (PedCIRB) Initiative: Progress and Impact

Go back to Resources

The NCI Pediatric Central Institutional Review Board (PedCIRB) Initiative: Progress and Impact

Authors:

Secondary:

Volume:

Publisher:

Abstract:

Go back to Resources

The National Institute of Neurological Disorders and Stroke (NINDS) Clinical Research Collaboration (CRC)

Go back to Resources

The National Institute of Neurological Disorders and Stroke (NINDS) Clinical Research Collaboration (CRC)

Authors:

Secondary:

Location:

Go back to Resources

Motor Function and Human Immunodeficiency Virus-Associated Cognitive Impairment in a Highly Active Antiretroviral Therapy-Era Cohort

Go back to Resources

Motor Function and Human Immunodeficiency Virus-Associated Cognitive Impairment in a Highly Active Antiretroviral Therapy-Era Cohort

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Late Outgrowth Endothelial Progenitor Cells in Patients with Age-Related Macular Degeneration

Go back to Resources

Late Outgrowth Endothelial Progenitor Cells in Patients with Age-Related Macular Degeneration

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids

Go back to Resources

Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Improved Outcomes with Home-Based Administration of Palivizumab: Results from the 2000-2004 Palivizumab Outcomes Registry

Go back to Resources

Improved Outcomes with Home-Based Administration of Palivizumab: Results from the 2000-2004 Palivizumab Outcomes Registry

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Immune Responses of Healthy Subjects to a Single Dose of Intramuscular Inactivated Influenza A/Vietnam/1203/2004 (H5N1) Vaccine After Priming with an Antigenic Variant

Go back to Resources

Immune Responses of Healthy Subjects to a Single Dose of Intramuscular Inactivated Influenza A/Vietnam/1203/2004 (H5N1) Vaccine After Priming with an Antigenic Variant

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 167
  • Page 168
  • Page 169
  • Page 170
  • Current page 171
  • Page 172
  • Page 173
  • Page 174
  • Page 175
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification